Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy

被引:119
作者
Li, Bing [1 ,2 ,3 ]
Liu, Shujun [2 ]
Miao, Lining [1 ]
Cai, Lu [3 ]
机构
[1] Jilin Univ, Dept Nephrol, Hosp 2, Changchun 130042, Peoples R China
[2] Jilin Prov Peoples Hosp, Dept Nephrol, Changchun 130041, Peoples R China
[3] Univ Louisville, KCHRI Pediat Diabet Res Labs, Dept Pediat, Louisville, KY 40202 USA
关键词
OXIDATIVE STRESS; BARDOXOLONE METHYL; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; CDDO-IMIDAZOLIDE; KIDNEY-FUNCTION; HYPERGLYCEMIA; DYSFUNCTION; RESVERATROL; TRITERPENOIDS;
D O I
10.1155/2012/216512
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic cardiomyopathy and nephropathy are two major causes of death of patients with diabetes. Extra generation of reactive oxygen species (ROS), induced by hyperglycemia, is considered as the main reason for the development of these diabetic complications. Transcription factor, NFE2-related factor 2 (Nrf2), is a master regulator of cellular detoxification response and redox status, and also provides a protective action from various oxidative stresses and damages. Recently we have demonstrated its important role in determining the susceptibility of cells or tissues to diabetes-induced oxidative stress and/or damage. Therefore, this review will specifically summarize the information available regarding the effect of Nrf2 on the diabetic complications with a focus on diabetic cardiomyopathy and nephropathy. Given the feature that Nrf2 is easily induced by several compounds, we also discussed the role of different Nrf2 activators in the prevention or therapy of various diabetic complications. These findings suggest that Nrf2 has a potential application in the clinic setting for diabetic patients in the short future.
引用
收藏
页数:7
相关论文
共 46 条
[1]  
Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
[2]   Nuclear Factor Erythroid 2-Related Factor 2 Deletion Impairs Glucose Tolerance and Exacerbates Hyperglycemia in Type 1 Diabetic Mice [J].
Aleksunes, Lauren M. ;
Reisman, Scott A. ;
Yeager, Ronnie L. ;
Goedken, Michael J. ;
Klaassen, Curtis D. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01) :140-151
[3]   Oxidative stress and diabetic cardiomyopathy: A brief review [J].
Cai L. ;
Kang Y.J. .
Cardiovascular Toxicology, 2001, 1 (3) :181-193
[4]   Nrf2 Activators as Attractive Therapeutics or Diabetic Nephropathy [J].
de Haan, Judy B. .
DIABETES, 2011, 60 (11) :2683-2684
[5]   Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2Akita diabetic mice [J].
Fujita, Hiroki ;
Fujishima, Hiromi ;
Morii, Tsukasa ;
Sakamoto, Takuya ;
Komatsu, Koga ;
Hosoba, Mihoko ;
Narita, Takuma ;
Takahashi, Keiko ;
Takahashi, Takamune ;
Yamada, Yuichiro .
HYPERTENSION RESEARCH, 2012, 35 (02) :213-220
[6]   Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: A role for Nrf2 in vascular protection in diabetes [J].
He, M. ;
Siow, R. C. M. ;
Sugden, D. ;
Gao, L. ;
Cheng, X. ;
Mann, G. E. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2011, 21 (04) :277-285
[7]   Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes [J].
He, Xiaoqing ;
Kan, Hong ;
Cai, Lu ;
Ma, Qiang .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 46 (01) :47-58
[8]   Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway [J].
Hur, Kyu Yeon ;
Kim, Soo Hyun ;
Choi, Min-Ah ;
Williams, Darren R. ;
Lee, Yong-ho ;
Kang, Sang Won ;
Yadav, Umesh C. S. ;
Srivastava, Satish K. ;
Jung, Mankil ;
Cho, Jin Won ;
Kim, Sang Geon ;
Kang, Eun Seok ;
Lee, Eun Jig ;
Lee, Hyun Chul .
ATHEROSCLEROSIS, 2010, 211 (01) :69-76
[9]   Dihydro-CDDO-Trifluoroethyl Amide (dh404), a Novel Nrf2 Activator, Suppresses Oxidative Stress in Cardiomyocytes [J].
Ichikawa, Tomonaga ;
Li, Jinqing ;
Meyer, Colin J. ;
Janicki, Joseph S. ;
Hannink, Mark ;
Cui, Taixing .
PLOS ONE, 2009, 4 (12)
[10]   High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells [J].
Inoguchi, T ;
Li, P ;
Umeda, F ;
Yu, HY ;
Kakimoto, M ;
Imamura, M ;
Aoki, T ;
Etoh, T ;
Hashimoto, T ;
Naruse, M ;
Sano, H ;
Utsumi, H ;
Nawata, H .
DIABETES, 2000, 49 (11) :1939-1945